Purchase Order 36C25618P1108
- Not listed
- This is a federal contract award to Organogenesis Inc., a regenerative medicine company specializing in advanced wound care, surgical biologics, and tissue regeneration products. The contract, valued at $3,028.00, was awarded on March 3, 2011 by the Veterans Integrated Service Network 17 (VISN 17), a component of the U.S. Department of Veterans Affairs (VA). The contract is for the supply of medical implants, with an ultimate completion date of April 3, 2011. This appears to be a Firm Fixed...
- This is a $11,880 firm fixed-price purchase order contract awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 21 to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products. The contract is for the provision of prosthetics, specifically spinal surgical implants and wound matrix products, to support medical treatments for veterans. Organogenesis is a key supplier of advanced wound care, surgical biologics, and tissue regeneration products...
- This is a firm fixed-price purchase order contract awarded by the Veterans Integrated Service Network 16 (VISN 16) of the Department of Veterans Affairs (VA) to Organogenesis Inc., a for-profit manufacturer of medical products. The $8,520 contract is for the delivery of surgical implants with a period of performance ending on February 13, 2014. Organogenesis holds several significant federal Indefinite Delivery Vehicles (IDVs) with the VA and Defense Logistics Agency (DLA) for a range of...
- This federal contract was awarded to Organogenesis Inc., a for-profit organization and manufacturer of goods, by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8. The contract is for the delivery of antimicrobial wound care dressings, with a potential value of $125,937.50. The contract is a Delivery Order under the Medical Equipment and Supplies Federal Supply Schedule (FSS-65-II-A). No set-aside designation was used. Organogenesis Inc....
- This federal contract award is for a vascular graft to be delivered to a VA hospital in Washington, D.C. The contract was awarded to Organogenesis Inc., a for-profit organization and manufacturer of regenerative medicine products. The contract is a firm fixed-price purchase order with a ceiling value of $7,170.00 and a completion date of December 10, 2010. Organogenesis is a key supplier of medical products to federal healthcare agencies, particularly the Department of Veterans Affairs (VA),...
- This is a firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products. The $3,028 contract is for the supply of IMPLANTS, with an ultimate completion date of April 7, 2011. Organogenesis is a leading provider of advanced wound care, surgical biologics, and tissue regeneration products to federal healthcare agencies, particularly the VA and Department of Defense. The company...
- This federal contract award, valued at $1,239.95, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA, worth $49.5 million, for wound care dressings and medical supplies. Organogenesis, headquartered in Canton, Massachusetts, specializes in advanced wound care, surgical biologics, and tissue...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts. The $1,239.95 fixed-price delivery order is for the supply of APLIGRAF, a skin substitute product, to support wound care and tissue regeneration for military personnel and veterans. Organogenesis is an established vendor for the Department of Veterans Affairs (VA) and DLA, holding several significant federal...
- This federal contract award, valued at $1,239.95, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit manufacturer of regenerative medical products. The contract is a delivery order for the advanced wound care product APLIGRAF. Organogenesis has multiple Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs (VA) and DLA, including a $25 million single-award IDC with the VA for surgical implants, a $30 million Federal...
- This federal contract award is for the delivery of APLIGRAF, a skin substitute product, to the Department of Defense (DoD) and the Department of Veterans Affairs (VA). The contract, awarded to Organogenesis Inc., a regenerative medicine company, has a ceiling value of $1,239.95 and a completion date of May 23, 2025. It is a Delivery Order contract with a Fixed Price with Economic Price Adjustment pricing type. The contract is not a set-aside. Organogenesis is a key supplier of advanced wound...
This federal contract award was made by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 to Organogenesis Inc., a leading regenerative medicine company. The contract, valued at $123,254.74, is for the delivery of surgical implants, wound care dressings and matrices, tissue regeneration products, and other medical supplies to support wound healing and tissue repair. Organogenesis Inc. has previously held prime contracts with the Department of Veterans Affairs and the Defense Logistics Agency Troop Support Medical to provide similar products. This contract is a firm fixed-price purchase order with no set-aside designation. Organogenesis Inc. also holds several indefinite delivery contracts and Federal Supply Schedule contracts with the Department of Veterans Affairs and the Defense Logistics Agency to provide a range of regenerative medicine solutions for wound and tissue repair over multiple years.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $123.3k | 11/14/17 |